Journal of Pathology Clinical Research

Papers
(The TQCC of Journal of Pathology Clinical Research is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
SWI/SNF‐deficiency defines highly aggressive undifferentiated endometrial carcinoma38
Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value35
Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications31
Combined CCNE1 high‐level amplification and overexpression is associated with unfavourable outcome in tubo‐ovarian high‐grade serous carcinoma30
Higher prevalence of pulmonary macrothrombi in SARS‐CoV‐2 than in influenza A: autopsy results from ‘Spanish flu’ 1918/1919 in Switzerland to Coronavirus disease 201927
DNA methylation‐based profiling of bone and soft tissue tumours: a validation study of the ‘DKFZ Sarcoma Classifier’26
Characterisation of cardiac pathology in 23 autopsies of lethal COVID‐1926
Adult‐type granulosa cell tumor of the ovary: a FOXL2‐centric disease26
Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore24
Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation23
Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases23
Hypothesis‐free deep survival learning applied to the tumour microenvironment in gastric cancer21
Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma20
The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients20
Semantic annotation for computational pathology: multidisciplinary experience and best practice recommendations19
Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid19
Sarcoma and the 100,000 Genomes Project: our experience and changes to practice19
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer19
Spatial analysis of tumor‐infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma19
Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer17
Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population17
The ethical challenges of artificial intelligence‐driven digital pathology16
Variability in grading of ductal carcinoma in situ among an international group of pathologists16
Immune cell infiltrates as prognostic biomarkers in pancreatic ductal adenocarcinoma: a systematic review and meta‐analysis15
Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features15
Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer15
Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas15
An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification14
Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response14
TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms13
Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma12
Quick Annotator: an open‐source digital pathology based rapid image annotation tool12
Expression of invadopodia markers can identify oral lesions with a high risk of malignant transformation12
Dysbalance of ACE2 levels – a possible cause for severe COVID‐19 outcome in COPD12
Loss of NF2 defines a genetic subgroup of non‐FOS‐rearranged osteoblastoma11
Expression of proteins associated with the Warburg‐effect and survival in colorectal cancer11
Immunohistochemistry for CCR4 C‐terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T‐cell leukemia/lymphoma11
More than just acral melanoma: the controversies of defining the disease11
Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types10
Explainability and causability in digital pathology10
MYC amplifications are common events in childhood osteosarcoma10
Morphological, immunohistochemical, and genetic analyses of bronchiolar adenoma and its putative variants10
Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas10
Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors10
Intra‐ and extra‐cranial BCOR‐ITD tumours are separate entities within the BCOR‐rearranged family10
CD24 is a surrogate for ‘immune‐cold’ phenotype in aggressive large B‐cell lymphoma10
pTDP‐43 aggregates accumulate in non‐central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical p9
PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules9
Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancer9
The presence of tumour‐infiltrating neutrophils is an independent adverse prognostic feature in clear cell renal cell carcinoma9
Colonic epithelial cathelicidin (LL‐37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate9
Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors9
An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours8
Reliable computational quantification of liver fibrosis is compromised by inherent staining variation8
Greater utility of molecular subtype rather than epithelial‐to‐mesenchymal transition (EMT) markers for prognosis in high‐risk non‐muscle‐invasive (HGT1) bladder cancer8
A distinct repertoire of cancer‐associated fibroblasts is enriched in cribriform prostate cancer8
Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma8
A combination of stromal PD‐L1 and tumoral nuclear β‐catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal ca8
Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy8
Malignant transformation of salivary gland pleomorphic adenoma: proof of principle8
A series of COVID‐19 autopsies with clinical and pathologic comparisons to both seasonal and pandemic influenza8
0.022838115692139